Subventricular Zone‐Derived Oligodendrogenesis in Injured Neonatal White Matter in Mice Enhanced by a Nonerythropoietic Erythropoietin Derivative
Open Access
- 13 August 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 30 (10), 2234-2247
- https://doi.org/10.1002/stem.1202
Abstract
Perinatal hypoxia‐ischemia (HI) frequently causes white‐matter injury, leading to severe neurological deficits and mortality, and only limited therapeutic options exist. The white matter of animal models and human patients with HI‐induced brain injury contains increased numbers of oligodendrocyte progenitor cells (OPCs). However, the origin and fates of these OPCs and their potential to repair injured white matter remain unclear. Here, using cell‐type‐ and region‐specific genetic labeling methods in a mouse HI model, we characterized the Olig2‐expressing OPCs. We found that after HI, Olig2+ cells increased in the posterior part of the subventricular zone (pSVZ) and migrated into the injured white matter. However, their oligodendrocytic differentiation efficiency was severely compromised compared with the OPCs in normal tissue, indicating the need for an intervention to promote their differentiation. Erythropoietin (EPO) treatment is a promising candidate, but it has detrimental effects that preclude its clinical use for brain injury. We found that long‐term postinjury treatment with a nonerythropoietic derivative of EPO, asialo‐erythropoietin, promoted the maturation of pSVZ‐derived OPCs and the recovery of neurological function, without affecting hematopoiesis. These results demonstrate the limitation and potential of endogenous OPCs in the pSVZ as a therapeutic target for treating neonatal white‐matter injury. STEM Cells2012;30:2234–2247Keywords
This publication has 97 references indexed in Scilit:
- Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalaciaExperimental Neurology, 2011
- Axin2 as regulatory and therapeutic target in newborn brain injury and remyelinationNature Neuroscience, 2011
- Adult Neurogenesis in the Mammalian Brain: Significant Answers and Significant QuestionsNeuron, 2011
- Timing of Appearance of Late Oligodendrocyte Progenitors Coincides with Enhanced Susceptibility of Preterm Rabbit Cerebral White Matter to Hypoxia-IschemiaJournal of Cerebral Blood Flow & Metabolism, 2010
- Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neuronsProceedings of the National Academy of Sciences of the United States of America, 2009
- 17β‐estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brainJournal of Neuroscience Research, 2009
- Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitisProceedings of the National Academy of Sciences of the United States of America, 2008
- Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injuryAnnals of Neurology, 2008
- Activation of the subventricular zone in multiple sclerosis: Evidence for early glial progenitorsProceedings of the National Academy of Sciences of the United States of America, 2007
- Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activitiesProceedings of the National Academy of Sciences of the United States of America, 2006